Does Escitalopram Cause Weight Gain?
Escitalopram, an SSRI antidepressant sold as Lexapro, can cause modest weight gain in some patients, though it's not universal. Clinical trials show average gains of 1-2 pounds over 6-12 months, with about 10-15% of users gaining 7% or more of body weight.[1][2] Long-term use (beyond a year) increases risk, as metabolism slows and appetite may rise due to serotonin effects on hunger signals.[3]
How Common Is Weight Gain on Escitalopram?
In short-term studies (8-12 weeks), weight gain occurs in under 5% of patients, often offset by initial loss.[1] Real-world data from over 100,000 users reports 7-10% experiencing gain after 6 months, rising to 15-25% after 2 years.[2][4] Women and those with binge-eating tendencies face higher odds.[3]
Why Does It Happen?
SSRIs like escitalopram boost serotonin, which curbs initial appetite but later disrupts leptin signaling, promoting fat storage and carb cravings. It may also reduce energy expenditure.[3][5] Unlike mirtazapine (strong weight gainer), escitalopram's effect is milder but cumulative.
How Much Weight Gain to Expect?
| Duration | Average Gain | % Gaining ≥7% Body Weight |
|----------|--------------|---------------------------|
| 3 months | 0.5-1 lb | 2-5% |
| 1 year | 1-3 lbs | 10-15% |
| 2+ years | 3-7 lbs | 20-25% |
Data from meta-analyses of RCTs and observational studies.[1][2][4] Individual factors like dose (10-20 mg typical), baseline BMI, and diet amplify this.
Compared to Other Antidepressants
Escitalopram causes less gain than paroxetine (up to 15 lbs average) or tricyclics, but more than bupropion (often weight-neutral or loss-inducing).[3][6]
- Minimal gain: Bupropion, vortioxetine.
- Moderate: Escitalopram, sertraline, fluoxetine.
- High: Mirtazapine, paroxetine.
What If You're Gaining Weight?
Monitor weekly; switch to bupropion or add metformin if gain exceeds 5-7%.[5] Lifestyle tweaks—exercise, low-carb diet—counteract 50-70% of gain in trials.[7] No FDA black-box warning, but discuss with doctor; abrupt stops risk withdrawal.[1]
[1]: FDA Lexapro Label
[2]: NNT Review on SSRIs
[3]: JAMA Psychiatry Meta-Analysis (2016)
[4]: BMJ Open Study (2021)
[5]: American Journal of Psychiatry (2019)
[6]: Lancet Psychiatry (2020)
[7]: Obesity Reviews (2018)